← Leaderboards
Bryan L Copple
Michigan State University
$4,193,159
Attributed
$4,906,461
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $729.3K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,906,461 · 11
By mechanism
R01$3,801,582 · 2
P20$652,196 · 7
R21$415,167 · 1
F32$37,516 · 1
Top collaborators
- James P Luyendyk3 shared
Most similar at Michigan State University
Same institution · by research overlap
- James P Luyendyk$12,779,466
- Robert Andrew Roth$10,177,038
Others in their field
Top investigators on “Liver”
- David Heimbrook · Leidos Biomedical Research, Inc.$183,557,534
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Richard Douglas Moore · Johns Hopkins University$59,048,354
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Michael S. Saag · University Of Alabama At Birmingham$50,288,385
- Mark A Kay · Stanford University$49,905,067
Research focus
LiverProteinsProductionLiver DiseasesHepatocytePathway InteractionsMolecularHepaticResponseMediatingPharmaceutical PreparationsSerumLiver FibrosisResearch PersonnelInflammationCholestasisInjuryBaseInflammatoryProgramsGrowthChemokineAcidsKnockout Mice
Grant awards (24)
Novel proteolytic mechanisms driving pathologic hepatic congestion in drug-induced hepatotoxicity$444,931
R01 · FY2025 · DK
Novel proteolytic mechanisms driving pathologic hepatic congestion in drug-induced hepatotoxicity$483,735
R01 · FY2024 · DK
Novel proteolytic mechanisms driving pathologic hepatic congestion in drug-induced hepatotoxicity$497,939
R01 · FY2023 · DK
Macrophage Phenotypic ModulatorsâA Novel Therapeutic Approach to Liver Fibrosis Treatment$226,997
R21 · FY2021 · AI · contact PI
Macrophage Phenotypic ModulatorsâA Novel Therapeutic Approach to Liver Fibrosis Treatment$188,170
R21 · FY2020 · AI · contact PI
Role of Early Growth Response Factor-1 in Cholestatic Liver Injury$264,273
R01 · FY2017 · DK · contact PI
Role of Early Growth Response Factor-1 in Cholestatic Liver Injury$264,541
R01 · FY2016 · DK · contact PI
Role of Early Growth Response Factor-1 in Cholestatic Liver Injury$262,350
R01 · FY2015 · DK · contact PI
Role of Early Growth Response Factor-1 in Cholestatic Liver Injury$198,474
R01 · FY2011 · DK · contact PI
Role of Early Growth Response Factor-1 in Cholestatic Liver Injury$117,153
R01 · FY2011 · DK · contact PI
COBRE: U OF KANSAS MEDICAL CTR: HISTOLOGY/PHENOTYPING CORE$37,932
P20 · FY2011 · RR · contact PI
Role of Early Growth Response Factor-1 in Cholestatic Liver Injury$292,370
R01 · FY2010 · DK · contact PI
COBRE: U OF KANSAS MEDICAL CTR: HISTOLOGY/PHENOTYPING CORE$35,552
P20 · FY2010 · RR · contact PI
Role of Early Growth Response Factor-1 in Cholestatic Liver Injury$295,323
R01 · FY2009 · DK · contact PI
COBRE: U OF KANSAS MEDICAL CTR: CORE D: HISTOLOGY/PHENOTYPING CORE$36,472
P20 · FY2009 · RR · contact PI
Role of Early Growth Response Factor-1 in Cholestatic Liver Injury$1,500
R01 · FY2009 · DK · contact PI
Role of Early Growth Response Factor-1 in Cholestatic Liver Injury$295,323
R01 · FY2008 · DK · contact PI
COBRE: U OF KANSAS MEDICAL CTR: CORE D: HISTOLOGY/PHENOTYPING CORE$33,097
P20 · FY2008 · RR · contact PI
Role of Early Growth Response Factor-1 in Cholestatic Liver Injury$301,350
R01 · FY2007 · DK · contact PI
PROJ 4: PHYSIOLOGICAL FUNCTION OF NUCLEAR RECEPTORS IN CHOLESTATIC LIVER DISEASE$226,461
P20 · FY2007 · RR · contact PI
COBRE: U OF KANSAS MEDICAL CTR: CORE D: HISTOLOGY/PHENOTYPING CORE$119,187
P20 · FY2007 · RR · contact PI
Role of Early Growth Response Factor-1 in Cholestatic Liver Injury$82,320
R01 · FY2007 · DK · contact PI
PROJ 4: PHYSIOLOGICAL FUNCTION OF NUCLEAR RECEPTORSIN CHOLESTATIC LIVER DIS$163,495
P20 · FY2006 · RR · contact PI
THROMBIN AND INFLAMMATORY TISSUE INJURY$37,516
F32 · FY2000 · ES